Doxorubicin administration by continuous infusion is not cardioprotective: the Dana-Farber 91-01 Acute Lymphoblastic Leukemia protocol.
Lipshultz SE, Giantris AL, Lipsitz SR, Kimball Dalton V, Asselin BL, Barr RD, Clavell LA, Hurwitz CA, Moghrabi A, Samson Y, Schorin MA, Gelber RD, Sallan SE, Colan SD.
Lipshultz SE, et al. Among authors: lipsitz sr.
J Clin Oncol. 2002 Mar 15;20(6):1677-82. doi: 10.1200/JCO.2002.20.6.1677.
J Clin Oncol. 2002.
PMID: 11896119
Clinical Trial.